These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10211927)

  • 1. New-onset panic attacks in a patient treated with olanzapine.
    Mandalos GE; Szarek BL
    J Clin Psychopharmacol; 1999 Apr; 19(2):191. PubMed ID: 10211927
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine versus other antipsychotics in the treatment of schizophrenia.
    Masand PS
    J Clin Psychiatry; 2001 Oct; 62(10):828-9. PubMed ID: 11816875
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of olanzapine as first-line schizophrenia therapy.
    Cohen LJ
    Am J Health Syst Pharm; 1999 Aug; 56(15):1559-60, 1563-4. PubMed ID: 10478999
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine: a new atypical antipsychotic.
    Littrell K; Peabody CD; Littrell SH
    J Psychosoc Nurs Ment Health Serv; 1996 Aug; 34(8):41-6. PubMed ID: 8856604
    [No Abstract]   [Full Text] [Related]  

  • 5. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine-induced manic-like syndrome.
    Lindenmayer JP; Klebanov R
    J Clin Psychiatry; 1998 Jun; 59(6):318-9. PubMed ID: 9671347
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.
    Bronson BD; Lindenmayer JP
    J Clin Psychopharmacol; 2000 Jun; 20(3):382-4. PubMed ID: 10831029
    [No Abstract]   [Full Text] [Related]  

  • 8. Marked reduction of tardive dyskinesia with olanzapine.
    Littrell KH; Johnson CG; Littrell S; Peabody CD
    Arch Gen Psychiatry; 1998 Mar; 55(3):279-80. PubMed ID: 9510225
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine and panic attacks.
    Etxebeste M; Aragüés E; Malo P; Pacheco L
    Am J Psychiatry; 2000 Apr; 157(4):659-60. PubMed ID: 10739446
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of olanzapine in refractory panic attacks.
    Khaldi S; Kornreich C; Dan B; Pelc I
    J Clin Psychopharmacol; 2003 Feb; 23(1):100-1. PubMed ID: 12544382
    [No Abstract]   [Full Text] [Related]  

  • 12. Writer's cramp induced by olanzapine.
    Vaamonde J; González JM; Hernádez A; Ibáñez R; Gudin MA; Del Real Francia MA
    J Neurol; 2001 May; 248(5):422. PubMed ID: 11437166
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergence of compulsive symptoms with olanzapine treatment.
    Mahendran R
    Aust N Z J Psychiatry; 2002 Aug; 36(4):565. PubMed ID: 12169167
    [No Abstract]   [Full Text] [Related]  

  • 14. Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment.
    Pozo P; Alcántara AG
    J Psychiatry Neurosci; 1998 Nov; 23(5):309-10. PubMed ID: 9846037
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersalivation coincident with olanzapine treatment.
    Perkins DO; McClure RK
    Am J Psychiatry; 1998 Jul; 155(7):993-4. PubMed ID: 9659875
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.
    Gray R
    Ment Health Care; 1998 Feb; 1(6):193-4. PubMed ID: 9791411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine-induced somnambulism.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2001 Jul; 158(7):1158. PubMed ID: 11431244
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
    Mujica R; Weiden P
    Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.